Search

everythinglearnresearchcommunity

for

Search:↓

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Transgender patients face unique skin issues due to hormone treatments and surgeries.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.

Hormonal therapies, especially antiandrogens, can help manage Hidradenitis Suppurativa.

Prenatal pesticide exposure may cause earlier breast development in girls.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

Men are more at risk for severe COVID-19 due to biological differences, suggesting the need for targeted treatments.

m6A deregulation plays a key role in PCOS and could lead to new treatments.

The transgender community in India has specific skin care needs and struggles to access dermatological services due to discrimination and financial issues.

Rosemary shows promise in treating alopecia, similar to minoxidil, but more research is needed.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Certain gene variations are linked to severe acne in Egyptian patients and could guide treatment choices.

Polycystic Ovary Syndrome (PCOS) is a common but often undiagnosed disorder in women that can cause irregular periods, infertility, and other symptoms, and can be managed with lifestyle changes, medication, and sometimes surgery.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Saw palmetto extract may help with hair loss and acne but needs more research on safety and long-term effects.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

Androgen self-administration might be controlled by membrane receptors, not nuclear ones.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Topical steroids help Erosive Lichen Planus, finasteride with birth control aids Female Pattern Hair Loss, young age helps Occupational Hand Eczema prognosis, quitting smoking is key for Diffuse Dermal Angiomatosis, and a 3-site Botulinum Toxin A injection is effective for glabellar wrinkles.

The composition with carnitine, thioctic acid, and saw palmetto extract may effectively reduce inflammation in hair follicle cells.

Analog 23 is a promising compound for prostate cancer treatment.

A woman had an allergic skin reaction to a hair loss treatment containing canrenone.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Personalized management and lifestyle changes are key to effectively managing PCOS.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.